(login)

Leading pharmaceutical
company in the Baltic States

Stock news


2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
Juris Bundulis has been reelected as the Chairman of the Board of JSC “«Grindeks»” for another term of the office
09.01.2015

Read more


RESOLUTION of the Extraordinary General Meeting of Shareholders of joint stock company «Grindeks» held on 22 December 2014
22.12.2014

Read more


The Financial Calendar of JSC «Grindeks» for the year of 2015
22.12.2014

Read more


DRAFT RESOLUTIONS of the Extraordinary General Meeting of Shareholders of joint stock company «Grindeks» to be held on 22 December 2014
08.12.2014

Read more


On JSC «Grindeks» financial results for nine months of 2014
28.11.2014

On Friday, on 28 November, the JSC «Grindeks» submitted the non-audited consolidated financial statements for nine months of 2014 to “NASDAQ OMX Riga”. Non-audited financial results indicate that turnover of the Group in the nine months of 2014 was 63.1 million euros and has decreased by 17.3 million euros or 21.5% in comparison to the nine months of 2013. While the Group’s net profit, attributable to shareholders of the parent company, was 3.7 million euros in the nine months of 2014 and has decreased by 4 million euros or 52.4% in comparison to the nine months of 2013. Gross profit margin in the nine months of 2014 was 58.3% while net profit margin was 5.8%. In the nine months of 2014 the Group’s production was exported to 57 countries worldwide, a total of 59.7 million euros which is 16.4 million euros or 21.5% less than in the nine months of 2013.

Read more